Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Seeing the site of treatment improves habitual pain but not cervical joint position sense immediately after manual therapy in chronic neck pain patients.

Beinert K, Lutz B, Zieglgänsberger W, Diers M.

Eur J Pain. 2018 Jul 12. doi: 10.1002/ejp.1290. [Epub ahead of print]

PMID:
29999203
2.

Visually induced analgesia during massage treatment in chronic back pain patients.

Löffler A, Trojan J, Zieglgänsberger W, Diers M.

Eur J Pain. 2017 Nov;21(10):1623-1631. doi: 10.1002/ejp.1066. Epub 2017 Jun 22.

PMID:
28639366
3.

Pain, opioids, and sleep: implications for restless legs syndrome treatment.

Trenkwalder C, Zieglgänsberger W, Ahmedzai SH, Högl B.

Sleep Med. 2017 Mar;31:78-85. doi: 10.1016/j.sleep.2016.09.017. Epub 2016 Nov 5. Review.

PMID:
27964861
4.

Corrigendum: Local Optogenetic Induction of Fast (20-40 Hz) Pyramidal-Interneuron Network Oscillations in the In Vitro and In Vivo CA1 Hippocampus: Modulation by CRF and Enforcement of Perirhinal Theta Activity.

Dine J, Genewsky A, Hladky F, Wotjak CT, Deussing JM, Zieglgänsberger W, Chen A, Eder M.

Front Cell Neurosci. 2016 Jun 10;10:148. doi: 10.3389/fncel.2016.00148. eCollection 2016.

5.

Local Optogenetic Induction of Fast (20-40 Hz) Pyramidal-Interneuron Network Oscillations in the In Vitro and In Vivo CA1 Hippocampus: Modulation by CRF and Enforcement of Perirhinal Theta Activity.

Dine J, Genewsky A, Hladky F, Wotjak CT, Deussing JM, Zieglgänsberger W, Chen A, Eder M.

Front Cell Neurosci. 2016 Apr 26;10:108. doi: 10.3389/fncel.2016.00108. eCollection 2016. Erratum in: Front Cell Neurosci. 2016;10:148.

6.

Watching your pain site reduces pain intensity in chronic back pain patients.

Diers M, Löffler A, Zieglgänsberger W, Trojan J.

Eur J Pain. 2016 Apr;20(4):581-5. doi: 10.1002/ejp.765. Epub 2015 Aug 18.

PMID:
26282334
7.

Infrared video microscopy for visualizing neurons and neuronal excitation in brain slices.

Dodt HU, Becker K, Zieglgänsberger W.

Cold Spring Harb Protoc. 2013 Dec 1;2013(12):1149-52. doi: 10.1101/pdb.prot079434.

PMID:
24298032
8.

Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.

Radbruch L, Glaeske G, Grond S, Münchberg F, Scherbaum N, Storz E, Tholen K, Zagermann-Muncke P, Zieglgänsberger W, Hoffmann-Menzel H, Greve H, Cremer-Schaeffer P.

Subst Abus. 2013;34(3):313-20. doi: 10.1080/08897077.2012.735216. Review.

PMID:
23844964
9.

Site-specific visual feedback reduces pain perception.

Diers M, Zieglgänsberger W, Trojan J, Drevensek AM, Erhardt-Raum G, Flor H.

Pain. 2013 Jun;154(6):890-6. doi: 10.1016/j.pain.2013.02.022. Epub 2013 Mar 1.

10.

Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates.

Webhofer C, Gormanns P, Reckow S, Lebar M, Maccarrone G, Ludwig T, Pütz B, Asara JM, Holsboer F, Sillaber I, Zieglgänsberger W, Turck CW.

J Psychiatr Res. 2013 Mar;47(3):289-98. doi: 10.1016/j.jpsychires.2012.11.003. Epub 2012 Dec 1.

PMID:
23207114
11.

Low dose isoflurane exerts opposing effects on neuronal network excitability in neocortex and hippocampus.

Becker K, Eder M, Ranft A, von Meyer L, Zieglgänsberger W, Kochs E, Dodt HU.

PLoS One. 2012;7(6):e39346. doi: 10.1371/journal.pone.0039346. Epub 2012 Jun 18.

12.

Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition.

Schmidt MV, Schülke JP, Liebl C, Stiess M, Avrabos C, Bock J, Wochnik GM, Davies HA, Zimmermann N, Scharf SH, Trümbach D, Wurst W, Zieglgänsberger W, Turck C, Holsboer F, Stewart MG, Bradke F, Eder M, Müller MB, Rein T.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17213-8. doi: 10.1073/pnas.1103318108. Epub 2011 Oct 3.

13.

Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation.

Webhofer C, Gormanns P, Tolstikov V, Zieglgänsberger W, Sillaber I, Holsboer F, Turck CW.

Transl Psychiatry. 2011 Dec 13;1:e58. doi: 10.1038/tp.2011.56.

14.

Formalin-induced fluorescence reveals cell shape and morphology in biological tissue samples.

Leischner U, Schierloh A, Zieglgänsberger W, Dodt HU.

PLoS One. 2010 Apr 28;5(4):e10391. doi: 10.1371/journal.pone.0010391.

15.

Anaesthesia monitoring by recurrence quantification analysis of EEG data.

Becker K, Schneider G, Eder M, Ranft A, Kochs EF, Zieglgänsberger W, Dodt HU.

PLoS One. 2010 Jan 26;5(1):e8876. doi: 10.1371/journal.pone.0008876.

16.

Anesthesia and postoperative cognitive dysfunction (POCD).

Jungwirth B, Zieglgänsberger W, Kochs E, Rammes G.

Mini Rev Med Chem. 2009 Dec;9(14):1568-79. Review.

PMID:
20088778
17.

Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.

Rammes G, Hosp C, Eisensamer B, Tanasic S, Nothdurfter C, Zieglgänsberger W, Rupprecht R.

PLoS One. 2009 Aug 21;4(8):e6715. doi: 10.1371/journal.pone.0006715.

18.

[Sleep quality, pain therapy. Summing up for the user].

Horlemann J, Blume H, Fischer J, Schwarz W, Vauth C, Zieglgänsberger W.

Dtsch Med Wochenschr. 2009 Jul;134 Suppl 4:S148-50. doi: 10.1055/s-0029-1222593. Epub 2009 Jun 24. German. No abstract available.

PMID:
19554498
19.

[Pain processing, pain memory and quality of sleep].

Horlemann J, Zieglgänsberger W.

Dtsch Med Wochenschr. 2009 Jul;134 Suppl 4:S127-31. doi: 10.1055/s-0029-1222588. Epub 2009 Jun 24. Review. German. No abstract available.

PMID:
19554493
20.

Resolution of ultramicroscopy and field of view analysis.

Leischner U, Zieglgänsberger W, Dodt HU.

PLoS One. 2009 Jun 3;4(6):e5785. doi: 10.1371/journal.pone.0005785.

21.

Isoflurane anaesthesia reversibly improves cognitive function and long-term potentiation (LTP) via an up-regulation in NMDA receptor 2B subunit expression.

Rammes G, Starker LK, Haseneder R, Berkmann J, Plack A, Zieglgänsberger W, Ohl F, Kochs EF, Blobner M.

Neuropharmacology. 2009 Mar;56(3):626-36. doi: 10.1016/j.neuropharm.2008.11.002. Epub 2008 Nov 27.

PMID:
19059421
22.

Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.

Haseneder R, Kratzer S, Kochs E, Eckle VS, Zieglgänsberger W, Rammes G.

Anesthesiology. 2008 Dec;109(6):998-1006. doi: 10.1097/ALN.0b013e31818d6aee.

PMID:
19034096
23.

Infrared-guided laser stimulation as a tool for elucidating the synaptic site of expression of long-term synaptic plasticity.

Rammes G, Eder M, Zieglgänsberger W, Dodt HU.

Methods Mol Biol. 2007;403:113-22. doi: 10.1007/978-1-59745-529-9_7.

PMID:
18827990
24.

Rückenschmerzen: Leitlinien der medikamentösen Therapie : Nutzen Sie das Therapiespektrum.

Wörz R, Müller-Schwefe G, Stroehmann I, Zeuner L, Zieglgänsberger W, Zimmermann M.

MMW Fortschr Med. 2008 Oct;150(48):3-10. doi: 10.1007/BF03365685. German. No abstract available.

PMID:
27372478
25.

The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons.

Deininger K, Eder M, Kramer ER, Zieglgänsberger W, Dodt HU, Dornmair K, Colicelli J, Klein R.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12539-44. doi: 10.1073/pnas.0801174105. Epub 2008 Aug 22.

26.

[Risk assessment in pain therapy].

Schoeffel D, Casser HR, Bach M, Kress HG, Likar R, Locher H, Steinleitner W, Strohmeier M, Brunner H, Treede RD, Zieglgänsberger W, Sandkühler J.

Schmerz. 2008 Oct;22(5):594-603. doi: 10.1007/s00482-008-0688-y. German.

PMID:
18604567
27.

The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole.

Rammes G, Zieglgänsberger W, Parsons CG.

J Neural Transm (Vienna). 2008 Aug;115(8):1119-26. doi: 10.1007/s00702-008-0059-y. Epub 2008 May 21.

28.

Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.

Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W.

CNS Neurosci Ther. 2008 Summer;14(2):107-19. doi: 10.1111/j.1527-3458.2008.00044.x. Review.

PMID:
18482024
29.

Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse.

Huge V, Rammes G, Beyer A, Zieglgänsberger W, Azad SC.

Eur J Pain. 2009 Feb;13(2):124-9. doi: 10.1016/j.ejpain.2008.03.010. Epub 2008 Apr 24.

PMID:
18439862
30.

Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala.

Azad SC, Kurz J, Marsicano G, Lutz B, Zieglgänsberger W, Rammes G.

Learn Mem. 2008 Mar 5;15(3):143-52. doi: 10.1101/lm.741908. Print 2008 Mar.

31.

Infrared-guided laser stimulation of neurons in brain slices.

Dodt HU, Eder M, Schierloh A, Zieglgänsberger W.

CSH Protoc. 2008 Jan 1;2008:pdb.prot4851. doi: 10.1101/pdb.prot4851.

PMID:
21356666
32.

Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain.

Dodt HU, Leischner U, Schierloh A, Jährling N, Mauch CP, Deininger K, Deussing JM, Eder M, Zieglgänsberger W, Becker K.

Nat Methods. 2007 Apr;4(4):331-6. Epub 2007 Mar 25.

PMID:
17384643
33.

Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity.

Schierloh A, Deussing J, Wurst W, Zieglgänsberger W, Rammes G.

Neurosci Lett. 2007 Apr 6;416(1):82-6. Epub 2007 Jan 26.

PMID:
17316992
34.

Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice.

Marsch R, Foeller E, Rammes G, Bunck M, Kössl M, Holsboer F, Zieglgänsberger W, Landgraf R, Lutz B, Wotjak CT.

J Neurosci. 2007 Jan 24;27(4):832-9.

35.

Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala.

Ranft A, Kurz J, Becker K, Dodt HU, Zieglgänsberger W, Rammes G, Kochs E, Eder M.

Neuropharmacology. 2007 Mar;52(3):716-23. Epub 2006 Nov 22.

PMID:
17123554
36.

The endocannabinoid system controls key epileptogenic circuits in the hippocampus.

Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wölfel B, Dodt HU, Zieglgänsberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B.

Neuron. 2006 Aug 17;51(4):455-66.

37.

Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.

Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, Zieglgänsberger W, Lutz B, Rammes G.

J Neurosci. 2006 May 24;26(21):5794-9. Erratum in: J Neurosci. 2006 Jun 14;26(24):table of contents.

38.

Excitatory amino acid neurotransmission.

Parsons CG, Danysz W, Zieglgänsberger W.

Handb Exp Pharmacol. 2005;(169):249-303.

PMID:
16594262
39.

[Endogenous cannabinoid system. Effect on neuronal plasticity and pain memory].

Azad SC, Huge V, Schöps P, Hilf C, Beyer A, Dodt HU, Rammes G, Zieglgänsberger W.

Schmerz. 2005 Nov;19(6):521-7. German.

PMID:
16328555
40.

Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains.

Eisensamer B, Uhr M, Meyr S, Gimpl G, Deiml T, Rammes G, Lambert JJ, Zieglgänsberger W, Holsboer F, Rupprecht R.

J Neurosci. 2005 Nov 2;25(44):10198-206.

41.

WIN 55,212-2 decreases the spatial spread of neocortical excitation in vitro.

Becker K, Eder M, Zieglgänsberger W, Dodt HU.

Neuroreport. 2005 Jun 21;16(9):993-6.

PMID:
15931075
42.

Understanding neuropathic pain.

Zieglgänsberger W, Berthele A, Tölle TR.

CNS Spectr. 2005 Apr;10(4):298-308. Review.

PMID:
15788957
43.

Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling.

Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgänsberger W, Rammes G.

J Neurosci. 2004 Nov 3;24(44):9953-61.

44.

Analgesic effects of 5-HT3 receptor antagonists.

Riering K, Rewerts C, Zieglgänsberger W.

Scand J Rheumatol Suppl. 2004;119:19-23. Review.

PMID:
15515407
45.

The potassium channel modulator flupirtine shifts the frequency-response function of hippocampal synapses to favour LTD in mice.

Azad SC, Eder M, Simon W, Hapfelmeier G, Dodt HU, Zieglgänsberger W, Rammes G.

Neurosci Lett. 2004 Nov 11;370(2-3):186-90.

PMID:
15488320
46.

Shining light on neurons--elucidation of neuronal functions by photostimulation.

Eder M, Zieglgänsberger W, Dodt HU.

Rev Neurosci. 2004;15(3):167-83. Review.

PMID:
15357140
47.

Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala.

Ranft A, Kurz J, Deuringer M, Haseneder R, Dodt HU, Zieglgänsberger W, Kochs E, Eder M, Hapfelmeier G.

Eur J Neurosci. 2004 Sep;20(5):1276-80.

PMID:
15341599
48.

Effects of sensory deprivation on columnar organization of neuronal circuits in the rat barrel cortex.

Schierloh A, Eder M, Zieglgänsberger W, Dodt HU.

Eur J Neurosci. 2004 Aug;20(4):1118-24.

PMID:
15305882
49.

Isoflurane reduces glutamatergic transmission in neurons in the spinal cord superficial dorsal horn: evidence for a presynaptic site of an analgesic action.

Haseneder R, Kurz J, Dodt HU, Kochs E, Zieglgänsberger W, Scheller M, Rammes G, Hapfelmeier G.

Anesth Analg. 2004 Jun;98(6):1718-23, table of contents.

PMID:
15155334
50.

Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.

Rammes G, Eisensamer B, Ferrari U, Shapa M, Gimpl G, Gilling K, Parsons C, Riering K, Hapfelmeier G, Bondy B, Zieglgänsberger W, Holsboer F, Rupprecht R.

Mol Psychiatry. 2004 Sep;9(9):846-58, 818.

PMID:
15024394

Supplemental Content

Loading ...
Support Center